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Objectives: In our study, the aim is to evaluate the use of Fresh-Frozen Plasma (FFP) in our emergency
department and to assess its audit for transfusion.
Methods: All the patients aged 18 and over who received FFP transfusion in the emergency department
between March 1, 2013 and March 1, 2016 were included into the study. The audit of FFP use was
evaluated by according to ‘British Committee for Standards in Hematology Guideline-2004’.
Results: Total 141 patients were identiﬁed to receive FFP transfusion in our emergency department.
When the audit of FFP use was evaluated, 59.6% of all the practices were regarded as improper use. We
identiﬁed that while the rate of improper use was 40.2% in patients with bleeding, it rose to 90.7% in
patients without active bleeding or in those who used FFP with the aim of bleeding prophylaxis.
Conclusion: We have determined that FFP transfusions were conducted with improper indications at
high rate in our emergency department. Preparing an up-to-date transfusion guideline for the practices
in emergency departments in our country and training and supervising the medical staff at regular in-
tervals may help prevent the shortcomings in FFP practices.
Copyright © 2016 The Emergency Medicine Association of Turkey. Production and hosting by Elsevier
B.V. on behalf of the Owner. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Fresh-Frozen Plasma (FFP) is the component that is prepared by
freezing various plasma factors from whole blood or from the
plasma collected through aphaeresis at the temperature and
duration at which they can keep their functions. FFP contains stable
coagulation factors, immunoglobulins and albumin at the same
level as that of typical plasma. This being the case, FFP can be
considered a costly therapeutic component, the source of which is
the human body.1
There are publications as regards the unnecessary and improper
use of FFP transfusion in recent years, which can assume a life-
saving role in cases that are really indicative of its use.2e6 With
an increase in the awareness of this issue, many guidelines have
been brought our concerning FFP transfusion, and the indications ofstirma Hastanesi, Pinarbasi,
cioren, Ankara, Turkey.
tar).
ncy Medicine Association of
e Association of Turkey. Production
ons.org/licenses/by-nc-nd/4.0/).FFP use are restricted.7,8 Unnecessary use of FFP is known to in-
crease the risk of side effects from the transfusion in patients, as
well as wasting sources and being costly. Excess volume replace-
ment, anaphylaxis, diseases transmitted through transfusion and
transfusion - based lung injury (TRALI) are the complications likely
to develop out of the use of FFP.9 In our country, there are not
sufﬁcient data available about transfusion practices particularly in
emergency departments. In our study, the aim is to analyze the use
of FFP in our emergency department and to assess its audit for
transfusion.2. Material and methods
2.1. Study design and setting
Our study was conducted in an emergency department at the
third step at which almost 250,000 patients are admitted annually.
Prior to the study, the approval was obtained from the local ethical
board. All the patients aged 18 and over who received FFP trans-
fusion in the emergency department between March 1, 2013 and
March 1, 2016 were included into the study. Pregnant womenwereand hosting by Elsevier B.V. on behalf of the Owner. This is an open access article
Table 2
Demographic characteristics and laboratory parameters of patients.
Sex [n (%)]
Female 63 (44.7%)
Age [median (minemax)] 74 (18e92)
Active bleeding [n (%)] 87 (61.7%)
Sites of bleeding [n (%)]
Intracranial 16 (18.4%)
Thorax 2 (2.3%)
Gastrointestinal tract 30 (34.5%)
Hematuria 3 (3.4%)
Epistaxis 17 (19.5%)
Vaginal 4 (4.6%)
Intraabdominal 8 (9.2%)
Other 7 (8%)
Coagulation parameters [median (minemax)]
Before FFP transfusion
INR 6.2 (1e25)
PT 71.5 (10.2e280)
PTT 52.4 (19.4e180)
After FFP transfusion
INR 2.5 (0.9e6.9)
PT 27.4 (10.8e78.2)
PTT 36.3 (21.1e125.7)
Total FFP units used for patients [unit] 311
Outcome in ED [n (%)]
Alive 132 (93.6%)
Exitus 9 (6.4%)
Indications of FFP usage in ED [n (%)]
Hepatic diseases 11 (7.8%)
Warfarin overdose 99 (70.2%)
Massive transfusion/trauma 18 (12.8%)
Prophylaxis for surgical procedures 8 (5.7%)
TTP/DIC 5 (3.5%)
FFP: Fresh frozen plasma.
AST; Aspartate transaminase, ALT; Alanine transaminase.
INR; International normalized ratio, PT; Prothrombin time, PTT; Partial prothrombin
time.
ED; Emergency department.
TTP; Thrombotic thrombocytopenic purpura.
DIC; Disseminated intravascular coagulation.
Table 3
Appropriateness of FFP use.
FFF use Appropriate
n (%)
Inappropriate
n (%)
Total
n (%)
Patients with bleeding 52 (59.8%) 35 (40.2%) 87 (61.7%)
No bleeding or prophylaxis
for surgery
5 (9.3%) 49 (90.7%) 54 (38.3%)
Total 57 (40.4%) 84 (59.6%) 141 (100%)
FFP: Fresh frozen plasma.
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blood count (CBC) and coagulation parameters before the trans-
fusion, FFP transfusion indications, bleeding areas if there was any,
and coagulation parameters after FFP were obtained from the
hospital automation system and from patient ﬁles through retro-
spective scanning. The patients who had missing data were
excluded. The audit of FFP use was evaluated by an emergency
physician according to the rules in ‘British Committee for Standards
in Hematology, blood transfusion, FFP, cryoprecipitate and the use
of cryosupernatant Guideline-2004’.8 The cases in which the use of
FFP is appropriate are given at Table 1.
2.2. Statistical analysis
The SPSS 16.0 for Windows (SPSS Inc., Chicago, IL) software was
used for the statistical analyses. The KolmogoroveSmirnov test was
used to assess the normal distribution of the variables. Regarding
digital data obtained by measurement, data that conforms to
normal distribution was shown as mean and standard deviation,
and data that does not conform to normal distribution was shown
as median and minimum - maximum. The categorical data ob-
tained by counting was shown as number (n) and percentage (%).
3. Results
Total 161 patients were identiﬁed to receive FFP transfusion in
the emergency department in the course of the study. Twenty
patients that had missing data were excluded, and the remaining
141 patients were included in the study. We determined that 311
units of FFP transfusion in total were carried out. When side effects
are evaluated in the study, we determined allergic reactions in four
patients, volume overload occurred in two patients. Demographic
data on the patients are presented on Table 2. As regards the pa-
tients' coagulation parameters that were examined prior to the
transfusion, it was established that the values of INR in 38 patients,
PT in 35 patients and PTT in 27 patients couldn't be measured by
the lab and/or that no result could be obtained as these values were
too high to be measured. The highest reference values in these
patients for coagulation parameters prior to the transfusion, which
were given by our lab, were accepted as 25 s for INR, 280 s for PT
and 180 s for PTT (Table 2).
The patients on whom FFP was practiced most frequently were
those inwhomwarfarin overdose (n ¼ 99, 70.2%) was detected. We
also determined that the rarest indication of FFP use was the FFP
transfusion (n ¼ 5, 3.5%) carried out due to TTP and DIC (Table 2).
When the audit of FFP use was evaluated, 59.6% of all the practices
were regarded as improper use. We identiﬁed that while the rate of
improper use was 40.2% in patients with bleeding, it increase to
90.7% in patients without active bleeding or in those who used FFP
with the aim of bleeding prophylaxis (Table 3).Table 1
Clinical indications for use of FFP.
Single-factor deﬁciencies where a speciﬁc or combined factor concentrate
is not available
Multiple-factor deﬁciencies and/or disseminated
intravascular coagulopathy
Thrombotic thrombocytopenic purpura
Need for urgent reversal of warfarin effect
Following massive transfusion in presence of bleeding and
prolonged coagulation
Liver disease in presence of bleeding or prolonged prothrombin time
(PT)-partial thromboplastin time (PTT)-international normalized ratio (INR)
in the settings of invasive procedures
FFP: Fresh frozen plasma.When we analyzed at the proper and improper use of FFP, we
determined that the most common indication in both cases was
warfarin overdose. Bleeding was present in 62 of the patients with
warfarin overdose (62.6%). FFP use in the patients with warfarin
overdose was proper at a rate of 33.3%, while a rate of 66.7% was
improper use of FFP (Table 4).
4. Discussion
FFP, which came into use in the 1940's, has gained more
importance in the clinic, and signiﬁcant rises are reported in its
use.8 For this reason, several guidelines have been published to
avoid unnecessary use and to establish a standard while clinicians
are deciding on the use of FFP.7,8 But, it is still reported in literature
that improper use of FFP is common despite these guidelines.3e5
However, sufﬁcient data are unavailable concerning the use of
FFP transfusion especially in emergency departments where
transfusion practices are numerous in our country.
Table 4
Appropriate and inappropriate use of FFP in various conditions.
Appropriate n (%) Inappropriate n (%)
Warfarin overdose 33 (57.9%) 66 (78.6%)
Hepatic diseases 5 (8.8%) 6 (7.1%)
Massive transfusion/trauma 14 (24.6%) 4 (4.8%)
Prophylaxis for surgery 3 (5.3%) 5 (6%)
TTP/DIC 2 (3.5%) 3 (3.6%)
Total 57 (100%) 84 (100%)
FFP: Fresh frozen plasma.
TTP; Thrombotic thrombocytopenic purpura.
DIC; Disseminated intravascular coagulation.
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the audit of the transfusion in emergency departments, we deter-
mined that improper use of FFP had a rate of 59.6%. In a study
conducted by Moylan et al in Australia, where there are more than
one national guideline about blood and blood products, it was re-
ported that 11% of the FFP transfusions were conducted with an
improper indication and 18% with an uncertain indication.10
Luk at al. determined the improper use of FFP to be 45% in
Canada, whereas, in Asian and European countries, the use of FFP
with an improper indication ranged from 21% to 78%.2,4,6,11,12 In a
study conducted in our country by Akkas¸ et al, the rate of improper
use was found to be 67%, which is similar to the result in our
study.13 The discrepancy between the results of the studies may
result from the differences in the national transfusion guidelines
that are prepared according to the existing needs and sources and
from the number of the centers included in the study. Besides, as a
result of the inclusion of more than one clinic in the study at the
center where the studywas conducted, different clinical algorithms
may have created a difference in FFP practices, thus affecting the
ﬁnal results of the study. The clinic that conducted FFP transfusion
with the most appropriate indication in the study by Moylan et al
was found to be a medical emergency clinic with a rate of 75%.10
The most commonly observed and the most signiﬁcant
complication of warfarin use is bleeding. In our study, we deter-
mined that the most common indication in the patients on whom
FFP transfusion was conducted was warfarin overdose, with a rate
of 70.2%. Warfarin overdose is one of the most commonly reported
causes of FFP use in literature, similar to the result of our study.14,15
However, guidelines don't recommend FFP transfusion to reverse
the effect of warfarin without the presence of severe active
bleeding.8 In our study, FFP transfusion in cases of warfarin over-
dose without active bleeding is regarded as improper use of FFP,
and this indication is determined to be the most common reason
for improper FFP practices, with a rate of 78.6%. In the study by Luk
et al, the most common improper FFP use was reported to be
present at active bleeding with PTT values normal or less than one
and a half times higher or at stages of preparation for surgical
procedures. In the same study, the indication of the reversal of oral
anticoagulant effect without bleeding was shown to be the rarest
reason for improper FFP use, which is inconsistent with the results
of our study.2 Similarly, in a study by Pahuja et al and in another one
by Lingegowda et al, it was reported that no improper FFP use was
seen to reverse warfarin effect in their patient groups.6,11 The
hospital where our study was conducted is located in a densely
populated area of settlement where the elderly are many in num-
ber; most of thosewho apply to the emergency department were of
geriatric patient population. In this age group, warfarin is used
more frequently due to atrial ﬁbrillation, cerebrovascular disease,
thromboembolism, which are more commonly seen with age, and
more medical inspection is demanded from elderly patients during
their emergency application. This was one of the reasons, in our
study, that enabled us to identify warfarin overdose as the mostcommon indication in improper FFP use, contrary to the data in
literature. When the change in bleeding parameters with the
transfusion of FFP was examined, we determined that the median
INR value was 6.15 and PT value was 71.5 s prior to the transfusion
in our study, whereas the median INR value decreased up to 2.46
and the PT value up to 27.4 s after the transfusion. Stanworth et al
reported the decrease to be 0.2 s for INR and 1.9 s for PT after the
FFP transfusion in adult patients in a wide series of 4635 diseases.
Also, they determined that, in mild and moderate INR and PT in-
creases, the effect of FFP transfusion on bleeding parameters were
slight and that, in sharp contrast with this, there was greater
reduction in extremely high INR and PT values with FFP trans-
fusion.5 Likewise, Abdel-Wahab et al reported in their study that
FFP transfusion had no effect on many patients for moderate PT
values.16 In our study, we had patients who are INR, PT and PTT
values couldn't be read by the devices in the lab or whose values
were too high to be read (38 patients for INR, 35 for PT and 27 for
PTT). The highest reference values that our lab gave for these pa-
tients were accepted as parameters. The higher number of these
patients in our study than in other studies could account for the
higher rate of reduction in bleeding parameters after the trans-
fusion in our study.
5. Limitations
Our study is a single centered, retrospective study. The low
number of cases is one of the limitations in our study. In addition,
there is the possibility of having missing and faulty information in
the record ﬁles of the patients in our study, which was conducted
retrospectively.
6. Conclusion
We have determined that FFP transfusions were used with
improper indications at a rate of high in the emergency depart-
ment. As well as causing a serious economic burden and loss of
sources, unnecessary FFP may be risky for the patients in terms of
complications. Preparing an up-to-date transfusion guideline for
the practices in emergency units in our country and training and
supervising the medical staff at regular intervals may help prevent
the deﬁcit in FFP practices.
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